Australia, Oct. 27 -- REGENXBIO Inc., owns the trademark (2683795) for 'REYSTORDYS' till June 12, 2036.
Status: protected:
Registered/protected
Class: 5 [Biological preparations for medical use in the treatment of genetic diseases and disorders, and muscle disorders, namely, Duchenne muscular dystrophy; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; pharmaceutical preparations for the treatment of genetic diseases and disorders, and muscle disorders, namely, Duchenne muscular dystrophy; clinical medical reagents for use in gene therapy; therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific ex...